Article

Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas.

Department of Neurological Surgery, University of California, San Francisco, California (M.C.O., M.E.I., M.Z.S., G.K., M.S., J.M.K., E.T.S., D.A., A.T.P.).
Neuro-Oncology (Impact Factor: 5.29). 12/2012; DOI: 10.1093/neuonc/nos286
Source: PubMed

ABSTRACT Background
Ependymoma is the most common glial tumor of the adult spinal cord. Current consensus recommends surgical resection with gross total resection (GTR) whenever possible. We performed a comprehensive review of the literature to evaluate whether adjuvant radiotherapy after subtotal resection (STR) has any benefit.MethodsA PubMed search was performed to identify adult patients with spinal cord ependymoma who underwent surgical resection. Only patients who had clearly defined extent of resection with or without adjuvant radiotherapy were included for analysis. Kaplan-Meier and multivariate Cox regression survival analyses were performed to determine the effects of adjuvant radiotherapy on progression-free survival (PFS) and overall survival (OS).ResultsA total of 348 patients underwent surgical resection of spinal cord ependymomas, where GTR was obtained in 77.0% (268/348) of patients. Among those who received STR, 58.8% (47/80) received adjuvant radiotherapy. PFS was significantly prolonged among those who received adjuvant radiotherapy after STR (log rank; P < .001). This prolonged PFS with adjuvant radiotherapy remained significant in multivariate Cox regression analysis (STR versus STR + RT group; hazard ratio (HR) = 2.26, P = .047). By contrast, improved OS was only associated with GTR (GTR versus STR + RT group; HR = 0.07, P = .001) and benign ependymomas (HR = 0.16, P = .001).Conclusions
Surgery remains the mainstay treatment for spinal cord ependymomas, where GTR provides optimal outcomes with longest PFS and OS. Adjuvant radiotherapy prolongs PFS after STR significantly, and OS is improved by GTR and benign tumor grade only.

0 Followers
 · 
94 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ependymomas are rare CNS tumors. Previous studies describing the clinical course of ependymoma patients were restricted to small sample sizes, often with patients at a specific institution.
    Neuro-Oncology 08/2014; DOI:10.1093/neuonc/nou162 · 5.29 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dear Editor:We read with interest a recent paper published by Yang et al. The authors reported their institutional experience of 15 grade II spinal cord ependymomas in children [1]. Gross total resection (GTR) was achieved in 12 cases. The remaining three underwent subtotal resection (STR) followed by radiotherapy (RT). While no tumor recurrence occurred in the GTR group, residual tumor regrowth was observed in two STR cases. Consequently, the author concluded that postoperative radiotherapy should be considered carefully due to uncertain therapeutic efficacy.We agree with the authors that there is a paucity of published data on the use of adjuvant radiotherapy in children with grade II/III spinal ependymomas. Pediatric intraspinal ependymomas are considered more aggressive than their adult counterparts [2]. All efforts must be made to achieve GRT [3]. It is generally agreed that RT is not necessary if the tumor has been removed completed [4]. In adults, progression-free survival (PFS) ...
    Child s Nervous System 02/2015; DOI:10.1007/s00381-015-2643-4 · 1.16 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Intracranial ependymomas are rare tumors in adults. Thus, factors affecting prognosis are poorly understood. We performed a study to investigate whether tumor location is an important prognostic factor in adults who undergo surgery for intracranial ependymomas. PubMed was searched to identify studies that reported clinical outcomes in adult patients with intracranial ependymoma. Data were extracted for patient and tumor characteristics, extent of resection, progression-free survival (PFS), and overall survival (OS). Tumors were categorized as supratentorial or infratentorial and extraventricular or intraventricular. Presenting clinical features and tumor characteristics were tabulated. Kaplan–Meier and multivariate Cox regression survival analyses were performed to determine PFS and OS by tumor location. Extent of resection was also analyzed by tumor location. A total of 183 patients were included in the meta-analysis. Patients presented at a mean of 8.2 months with a myriad of clinical features. The mean tumor size was 3.38 cm, and 19.3% of tumors were cystic. Supratentorial tumors were most commonly located in the frontal and parietal lobes, and infratentorial tumors in the fourth ventricle. Supratentorial tumors demonstrated significantly poorer PFS (p < 0.001) and OS (p = 0.003) than infratentorial tumors, despite a higher rate of gross total resection (GTR) for the supratentorial tumors (72.6% versus 42.1%). Extraventricular ependymomas displayed significantly poorer PFS than intraventricular ependymomas (p = 0.009). In summary, supratentorial ependymomas have significantly poorer PFS and OS than their infratentorial counterparts, despite being more conducive to GTR, suggesting increased clinical aggressiveness. Extraventricular location is also associated with significantly poorer PFS than intraventricular location.
    Journal of Clinical Neuroscience 12/2014; 21(12). DOI:10.1016/j.jocn.2014.05.011 · 1.32 Impact Factor